Incidence and Predictors of Hyperkalemia in Patients With Heart Failure An Analysis of the CHARM Program

Abstract

OBJECTIVES: We explored the incidence and predictors of hyperkalemia in a broad population of heart failure patients. BACKGROUND: When used in optimal doses to treat patients with heart failure, renin-angiotensin-aldosterone system (RAAS) inhibitors improve clinical outcomes but can cause hyperkalemia.

Authors

Desai AS; Swedberg K; McMurray JJV; Granger CB; Yusuf S; Young JB; Dunlap ME; Solomon SD; Hainer JW; Olofsson B

Journal

Journal of the American College of Cardiology, Vol. 50, No. 20, pp. 1959–1966

Publisher

Elsevier

Publication Date

11 2007

DOI

10.1016/j.jacc.2007.07.067

ISSN

0735-1097

Associated Experts

Salim Yusuf

Professor, Faculty of Health Sciences

Visit profile

Labels